Evidence map›Paper›PMID 26216270›Full record

ArticleInternational journal of clinical pharmacy2015

Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.

Thamir M Alshammari, Khaled K Alamri, Yazeed A Ghawa, Noura F Alohali, Shaza A Abualkol, Hisham S Aljadhey

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thamir M AlshammariCollege of Pharmacy, University of Hail, Hail, Saudi Arabia. Thamer.alshammary@gmail.com.
Khaled K AlamriCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Yazeed A GhawaCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Noura F AlohaliCollege of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Shaza A AbualkolCollege of Pharmacy, University of Hail, Hail, Saudi Arabia.
Hisham S AljadheyMedication Safety Research Chair, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDrug safety has major implications for patients' lives. However, this concept is still considered new to some healthcare professionals.

objectiveThis study aims to investigate the knowledge and awareness of Saudi healthcare professionals to pharmacovigilance (PV). Setting Governmental and private hospitals at three main cities in Saudi Arabia (Riyadh, Jeddah, and Dammam).

methodsA cross-sectional survey among healthcare professionals (pharmacists, physicians, and nurses) within 12 Saudi hospitals was conducted between November and December 2012. The questionnaire consisted of 18 questions assessing the knowledge, awareness, and attitude of healthcare professionals (HCPs) towards science and the concept of PV. Descriptive statistics were used to analyze the data. The data were analyzed using Statistical Analysis Software (SAS 9.3). Main outcome measure Knowledge, attitude and practice of HCPs toward pharmacovigilance.

resultsThree-hundred and thirty-two healthcare professionals completed the survey (response rate 72 %), 110 (34 %) physicians, 106 (33 %) pharmacists, and 104 (32 %) nurses. More than half of the participants (55 %) did not know the correct definition of PV. Two-thirds of the respondents, 207 (65.5 %), had knowledge of the aim of post-marketing surveillance, yet only 113 (36.9 %) were aware that the National Pharmacovigilance and Drug Safety Center is the official body for monitoring adverse drug reaction in Saudi Arabia. In addition, 34.7 % agreed that lack of time could be a major barrier for reporting. The majority of the respondents (78.4 %) believed that reporting was a professional obligation and hospitals should have a drug safety department.

conclusionsThere was a limited knowledge of pharmacovigilance that could have affected reporting incidence. Educational intervention and a practical training program need to be applied by the drug regulatory body as well as health authorities to enhance the pharmacovigilance and drug safety culture in Saudi Arabia.

Indexed as

Attitude of Health PersonnelHealth Knowledge, Attitudes, PracticePharmacovigilanceAdverse Drug Reaction Reporting SystemsCross-Sectional StudiesDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleSaudi ArabiaTime FactorsHealthcare professionalHospitalKnowledge and attitudePharmacovigilanceSaudi Arabia

Identifiers

PMID26216270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.